Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health

JACC: Cardiovascular Imaging

Volumn 3, Issue 6, 2010, Pages 623-640

  Schindler, Thomas H ^a   Schelbert, Heinrich R ^b   Quercioli, Alessandra ^a   Dilsizian, Vasken ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular disease prevention; coronary artery disease; coronary circulation; endothelium y microcirculation; myocardial blood flow; myocardial flow reserve; positron emission tomography

Indexed keywords

AMLODIPINE; AMMONIA N 13; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; GLIBENCLAMIDE; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; OLMESARTAN; PROGESTERONE; RUBIDIUM 82; STRONTIUM 82; TECHNETIUM 99M; THALLIUM 201; WATER O 15; RADIOPHARMACEUTICAL AGENT;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE MARKER; DRUG HALF LIFE; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE BLOOD FLOW; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MYOCARDIAL PERFUSION IMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DIAGNOSTIC USE; FRACTIONAL FLOW RESERVE; HYPEREMIA; MICROCIRCULATION; MICROVASCULATURE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; SEVERITY OF ILLNESS INDEX;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; HYPEREMIA; MICROCIRCULATION; MICROVESSELS; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956658504     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2010.04.007     Document Type: Review

References (116)

1. R. Vedanthan, and V. Fuster Disease prevention: the moving target of global cardiovascular health Nat Rev Cardiol 6 2009 327 328
2. R.H. Eckel, S.R. Daniels, A.K. Jacobs, and R.M. Robertson America's children: a critical time for prevention Circulation 111 2005 1866 1868
3. M.E. Mendelsohn, and R.H. Karas HRT and the young at heart N Engl J Med 356 2007 2639 2641
4. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
5. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
7. J.A. Dormandy, B. Charbonnel, and D.J. Eckland Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289
8. T.H. Schindler, X.L. Zhang, G. Vincenti, L. Mhiri, R. Lerch, and H.R. Schelbert Role of PET in the evaluation and understanding of coronary physiology J Nucl Cardiol 14 2007 589 603 (Pubitemid 47163562)
9. P.G. Camici, and F. Crea Coronary microvascular dysfunction N Engl J Med 356 2007 830 840
10. D. Neglia, C. Michelassi, and M.G. Trivieri Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction Circulation 105 2002 186 193
11. A. Lerman, and A.M. Zeiher Endothelial function: cardiac events Circulation 111 2005 363 368
12. T.H. Schindler, E.U. Nitzsche, and H.R. Schelbert Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events J Am Coll Cardiol 45 2005 1505 1512
13. B.A. Herzog, L. Husmann, and I. Valenta Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve J Am Coll Cardiol 54 2009 150 156
14. R.A. Tio, A. Dabeshlim, and H.M. Siebelink Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease J Nucl Med 50 2009 214 219
15. M. Graner, M. Varpula, and J. Kahri Association of carotid intima-media thickness with angiographic severity and extent of coronary artery disease Am J Cardiol 97 2006 624 629 (Pubitemid 43255027)
16. U. Hoffmann, J.T. Nagurney, and F. Moselewski Coronary multidetector computed tomography in the assessment of patients with acute chest pain Circulation 114 2006 2251 2260
17. S. Achenbach, V. Dilsizian, C.M. Kramer, and W.A. Zoghbi The year in coronary artery disease J Am Coll Cardiol Img 2 2009 774 786
18. K.G. Reddy, R.N. Nair, H.M. Sheehan, and J.M. Hodgson Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis J Am Coll Cardiol 23 1994 833 843
19. F.M. Bengel, T. Higuchi, M.S. Javadi, and R. Lautamaki Cardiac positron emission tomography J Am Coll Cardiol 54 2009 1 15
20. P.G. Camici, and O.E. Rimoldi The clinical value of myocardial blood flow measurement J Nucl Med 50 2009 1076 1087
21. P. Ganz, and J.A. Vita Testing endothelial vasomotor function: nitric oxide, a multipotent molecule Circulation 108 2003 2049 2053
22. K. Yoshinaga, R. Klein, and N. Tamaki Generator-produced rubidium-82 positron emission tomography myocardial perfusion imaging-From basic aspects to clinical applications J Cardiol 55 2010 163 173
23. I. Adachi, O. Gaemperli, and I. Valenta Assessment of myocardial perfusion by dynamic O-15-labeled water PET imaging: validation of a new fast factor analysis J Nucl Cardiol 14 2007 698 705
24. S.S. Gambhir, M. Schwaiger, and S.C. Huang Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose J Nucl Med 30 1989 359 366
25. I.N. Weinberg, S.C. Huang, and E.J. Hoffman Validation of PET-acquired input functions for cardiac studies J Nucl Med 29 1988 241 247
26. H.R. Schelbert Positron emission tomography of the heart: methodology, findings in the normal and the diseased heart, and clinical applications M. Phelps, PET: Molecular Imaging and Its Biological Applications 2005 Springer-Verlag New York, NY 389 508
27. M.R. Vesely, and V. Dilsizian Nuclear cardiac stress testing in the era of molecular medicine J Nucl Med 49 2008 399 413
28. O. Muzik, R.S. Beanlands, G.D. Hutchins, T.J. Mangner, N. Nguyen, and M. Schwaiger Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET J Nucl Med 34 1993 83 91
29. W.G. Kuhle, G. Porenta, and S.C. Huang Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging Circulation 86 1992 1004 1017
30. S.R. Bergmann, K.A. Fox, and A.L. Rand Quantification of regional myocardial blood flow in vivo with H215O Circulation 70 1984 724 733
31. L.I. Araujo, A.A. Lammertsma, and C.G. Rhodes Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography Circulation 83 1991 875 885
32. M. Schwaiger, and O. Muzik Assessment of myocardial perfusion by positron emission tomography Am J Cardiol 67 1991 35D 43D
33. E.U. Nitzsche, Y. Choi, J. Czernin, C.K. Hoh, S.C. Huang, and H.R. Schelbert Noninvasive quantification of myocardial blood flow in humans A direct comparison of the [13N]ammonia and the [15O]water techniques Circulation 93 1996 2000 2006
34. A. Bol, J.A. Melin, and J.L. Vanoverschelde Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres Circulation 87 1993 512 525
35. B.J. Chow, R.S. Beanlands, and A. Lee Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography J Am Coll Cardiol 47 2006 411 416
36. J. Knuuti, S. Kajander, M. Maki, and H. Ukkonen Quantification of myocardial blood flow will reform the detection of CAD J Nucl Cardiol 16 2009 497 506
37. J. Machac, S.L. Bacharach, and T.M. Bateman Positron emission tomography myocardial perfusion and glucose metabolism imaging J Nucl Cardiol 13 2006 e121 e151
38. V. Dilsizian, S.L. Bacharach, and R.S. Beanlands PET myocardial perfusion and metabolism clinical imaging J Nucl Cardiol 16 2009 651
39. G. El Fakhri, A. Sitek, B. Guerin, M.F. Kijewski, M.F. Di Carli, and S.C. Moore Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses J Nucl Med 46 2005 1264 1271
40. J.W. Lin, R.R. Sciacca, R.L. Chou, A.F. Laine, and S.R. Bergmann Quantification of myocardial perfusion in human subjects using 82Rb and wavelet-based noise reduction J Nucl Med 42 2001 201 208
41. M. Lortie, R.S. Beanlands, K. Yoshinaga, R. Klein, J.N. Dasilva, and R.A. DeKemp Quantification of myocardial blood flow with 82Rb dynamic PET imaging Eur J Nucl Med Mol Imaging 34 2007 1765 1774
42. S.G. Nekolla, S. Reder, and A. Saraste Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model Circulation 119 2009 2333 2342
43. H.M. Sherif, A. Saraste, and E. Weidl Evaluation of a novel (18)F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats Circ Cardiovasc Imaging 2 2009 77 84
44. R. Hachamovitch, S.W. Hayes, J.D. Friedman, I. Cohen, and D.S. Berman Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD J Am Coll Cardiol 43 2004 200 208
45. L.J. Shaw, D.S. Berman, and D.J. Maron Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
46. L.J. Shaw, J.K. Min, and R. Hachamovitch Cardiovascular imaging research at the crossroads J Am Coll Cardiol Img 3 2010 316 324
47. R. Hachamovitch, X. Kang, and A.M. Amanullah Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly Circulation 120 2009 2197 2206
48. T.H. Schindler, R. Campisi, and D. Dorsey Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors Eur Heart J 30 2009 978 986
49. T.H. Schindler, J. Cardenas, and J.O. Prior Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function J Am Coll Cardiol 47 2006 1188 1195
50. T.H. Schindler, A.D. Facta, and J.O. Prior Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus Eur J Nucl Med Mol Imaging 36 2009 219 229
51. R.S. Lima, D.D. Watson, and A.R. Goode Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease J Am Coll Cardiol 42 2003 64 70
52. G.A. Beller Underestimation of coronary artery disease with SPECT perfusion imaging J Nucl Cardiol 15 2008 151 153
53. T.H. Schindler, I. Valenta, and V. Dilsizian PET assessment of myocardial perfusion V. Dilsizian, G.M. Pohost, Cardiac CT, PET and MRI. 2nd edition 2010 Wiley-Blackwell Oxford, United Kingdom 95 117
54. L.I. Heller, C. Cates, J. Popma FACTS Study Group Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography Circulation 96 1997 484 490
55. N.G. Uren, P. Marraccini, R. Gistri, R. de Silva, and P.G. Camici Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease J Am Coll Cardiol 22 1993 650 658
56. K.L. Gould Does coronary flow trump coronary anatomy? J Am Coll Cardiol Img 2 2009 1009 1023
57. K.L. Gould Coronary flow reserve and pharmacologic stress perfusion imaging: beginnings and evolution J Am Coll Cardiol Img 2 2009 664 669
58. D.S. Berman, X. Kang, and P.J. Slomka Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease J Nucl Cardiol 14 2007 521 528
59. W.H. Smith, R.J. Kastner, D.A. Calnon, D. Segalla, G.A. Beller, and D.D. Watson Quantitative gated single photon emission computed tomography imaging: a counts-based method for display and measurement of regional and global ventricular systolic function J Nucl Cardiol 4 1997 451 463 (Pubitemid 28043896)
60. S. Dorbala, R. Hachamovitch, and Z. Curillova Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF J Am Coll Cardiol Img 2 2009 846 854
61. S. Dorbala, D. Vangala, U. Sampson, A. Limaye, R. Kwong, and M.F. Di Carli Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study J Nucl Med 48 2007 349 358
62. B.J. Pichler, H.F. Wehrl, and M.S. Judenhofer Latest advances in molecular imaging instrumentation J Nucl Med 49 Suppl 2 2008 5S 23S
63. U.K. Sampson, S. Dorbala, A. Limaye, R. Kwong, and M.F. Di Carli Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease J Am Coll Cardiol 49 2007 1052 1058
64. M.F. Di Carli Advances in positron emission tomography J Nucl Cardiol 11 2004 719 732
65. T.M. Bateman, G.V. Heller, and A.I. McGhie Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT J Nucl Cardiol 13 2006 24 33
66. R.T. Go, T.H. Marwick, and W.J. MacIntyre A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease J Nucl Med 31 1990 1899 1905
67. R.E. Stewart, M. Schwaiger, and E. Molina Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease Am J Cardiol 67 1991 1303 1310
68. D. Keane, J. Haase, and C.J. Slager Comparative validation of quantitative coronary angiography systems Results and implications from a multicenter study using a standardized approach Circulation 91 1995 2174 2183
69. N.G. Uren, J.A. Melin, B. de Bruyne, W. Wijns, T. Baudhuin, and P.G. Camici Relation between myocardial blood flow and the severity of coronary-artery stenosis N Engl J Med 330 1994 1782 1788
70. J. Krivokapich, J. Czernin, and H.R. Schelbert Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease J Am Coll Cardiol 28 1996 565 572
71. M. Di Carli, J. Czernin, and C.K. Hoh Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease Circulation 91 1995 1944 1951
72. L.L. Demer, K.L. Gould, and R.A. Goldstein Assessment of coronary artery disease severity by positron emission tomography Comparison with quantitative arteriography in 193 patients Circulation 79 1989 825 835
73. A. Sato, M. Hiroe, and M. Tamura Quantitative measures of coronary stenosis severity by 64-slice CT angiography and relation to physiologic significance of perfusion in nonobese patients: comparison with stress myocardial perfusion imaging J Nucl Med 49 2008 564 572
74. D. Baller, G. Notohamiprodjo, U. Gleichmann, J. Holzinger, R. Weise, and J. Lehmann Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis Circulation 99 1999 2871 2875
75. G.B. Mancini, G.C. Henry, and C. Macaya Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease The TREND (Trial on Reversing ENdothelial Dysfunction) Study Circulation 94 1996 258 265
76. P. Meier, S. Gloekler, and R. Zbinden Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements Circulation 116 2007 975 983
77. M.M. Hajjiri, M.B. Leavitt, H. Zheng, A.E. Spooner, A.J. Fischman, and H. Gewirtz Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location J Am Coll Cardiol Img 2 2009 751 758
78. P.G. Camici Absolute figures are better than percentages J Am Coll Cardiol Img 2 2009 759 760
79. S.V. Nesterov, C. Han, and M. Maki Myocardial perfusion quantitation with (15)O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas) Eur J Nucl Med Mol Imaging 36 2009 1594 1602
80. C. Anagnostopoulos, A. Almonacid, and G. El Fakhri Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity Eur J Nucl Med Mol Imaging 35 2008 1593 1601
81. J.O. Prior, M.J. Quinones, and M. Hernandez-Pampaloni Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus Circulation 111 2005 2291 2298
82. P.A. Kaufmann, T. Gnecchi-Ruscone, K.P. Schafers, T.F. Luscher, and P.G. Camici Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia J Am Coll Cardiol 36 2000 103 109
83. Melikian N, De Bondt P, Tonino P, et al. Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. J Am Coll Cardiol Intv;3:30714.
84. Beller GA, Ragosta M. Decision making in multivessel coronary disease: the need for physiological lesion assessment. J Am Coll Cardiol Intv;3:3157.
85. T. Tsukamoto, K. Morita, and M. Naya Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease Eur J Nucl Med Mol Imaging 33 2006 1150 1156
86. S. Dorbala, A. Hassan, T. Heinonen, H.R. Schelbert, and M.F. Di Carli Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease J Nucl Cardiol 13 2006 761 767
87. M.B. Britten, A.M. Zeiher, and V. Schachinger Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome Coron Artery Dis 15 2004 259 264
88. M.J. Quinones, M. Hernandez-Pampaloni, and H. Schelbert Coronary vasomotor abnormalities in insulin-resistant individuals Ann Intern Med 140 2004 700 708
89. R. Campisi, L. Nathan, and M.H. Pampaloni Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration Circulation 105 2002 425 430
90. R. Campisi, J. Czernin, H. Schoder, J.W. Sayre, and H.R. Schelbert L-Arginine normalizes coronary vasomotion in long-term smokers Circulation 99 1999 491 497
91. T.H. Schindler, E.U. Nitzsche, and M. Olschewski Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors Circulation 110 2004 1069 1075
92. T. Munzel, A. Daiber, V. Ullrich, and A. Mulsch Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase Arterioscler Thromb Vasc Biol 25 2005 1551 1557
93. T.H. Marwick, K. Shan, S. Patel, R.T. Go, and M.S. Lauer Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease Am J Cardiol 80 1997 865 870
94. K. Yoshinaga, B.J. Chow, and K. Williams What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 48 2006 1029 1039
95. F. Cecchi, I. Olivotto, R. Gistri, R. Lorenzoni, G. Chiriatti, and P.G. Camici Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy N Engl J Med 349 2003 1027 1035
96. P.O. Bonetti, L.O. Lerman, and A. Lerman Endothelial dysfunction: a marker of atherosclerotic risk Arterioscler Thromb Vasc Biol 23 2003 168 175
97. T.H. Schindler, X.L. Zhang, and J.O. Prior Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET Eur J Nucl Med Mol Imaging 34 2007 1178 1188
98. S. Sawada, O. Muzik, R.S. Beanlands, E. Wolfe, G.D. Hutchins, and M. Schwaiger Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography J Nucl Cardiol 2 1995 413 422
99. P.A. Kaufmann, T. Gnecchi-Ruscone, J.T. Yap, O. Rimoldi, and P.G. Camici Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET J Nucl Med 40 1999 1848 1856
100. T.H. Schindler, E.U. Nitzsche, and M. Olschewski PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography J Nucl Med 45 2004 419 428
101. J. Czernin, P. Muller, and S. Chan Influence of age and hemodynamics on myocardial blood flow and flow reserve Circulation 88 1993 62 69
102. O. Manabe, K. Yoshinaga, C. Katoh, M. Naya, R.A. deKemp, and N. Tamaki Repeatability of rest and hyperemic myocardial blood flow measurements with 82Rb dynamic PET J Nucl Med 50 2009 68 71
103. S. Nagamachi, J. Czernin, and A.S. Kim Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET J Nucl Med 37 1996 1626 1631
104. C.A. Wyss, P. Koepfli, K. Mikolajczyk, C. Burger, G.K. von Schulthess, and P.A. Kaufmann Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress J Nucl Med 44 2003 146 154
105. G. El Fakhri, A. Kardan, and A. Sitek Reproducibility and accuracy of quantitative myocardial blood flow assessment with 82Rb PET: comparison with 13N-ammonia PET J Nucl Med 50 2009 1062 1071
106. P.T. Siegrist, O. Gaemperli, and P. Koepfli Repeatability of cold pressor test-induced flow increase assessed with H(2)(15)O and PET J Nucl Med 47 2006 1420 1426
107. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
108. R. Jagathesan, P.A. Kaufmann, and S.D. Rosen Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease J Nucl Med 46 2005 212 219
109. P. Wielepp, D. Baller, U. Gleichmann, E. Pulawski, D. Horstkotte, and W. Burchert Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease Eur J Nucl Med Mol Imaging 32 2005 1371 1377
110. T.H. Schindler, A.D. Facta, and J.O. Prior Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes Heart 93 2007 345 349
111. J. Czernin, R.J. Barnard, and K.T. Sun Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve Circulation 92 1995 197 204
112. S. Fichtlscherer, S. Breuer, and A.M. Zeiher Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient Circulation 110 2004 1926 1932
113. M.G. Modena, L. Bonetti, F. Coppi, F. Bursi, and R. Rossi Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women J Am Coll Cardiol 40 2002 505 510
114. H.R. Schelbert Quantifying myocardial perfusion for the assessment of preclinical CAD M.F. Di Carli, M.J. Lipton, Cardiac PET and PET/CT Imaging 2007 Springer New York, NY 166 177
115. T.H. Schindler, J. Cadenas, and A.D. Facta Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus Eur Heart J 30 2009 3064 3073
116. M. Naya, T. Tsukamoto, and K. Morita Olmesartan but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients J Am Coll Cardiol 50 2007 1144 1149